Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically
Fournier's Gangrene is a genital flesh-eating form of necrotizing fasciitis
Monday, February 11, 2019 - Fournier's Gangrene may be one of if not the scariest diseases in the world as the treatment often requires the amputation of the male genitalia. Upwards of 70% of all Fournier's Gangrene patients die and those that live are faced with three months of hospitalization including a series of debridements of dead flesh in the hope of stopping this fast-spreading disease. Fournier's Gangrene survivors continue to be faced with scourage of diabetes and fear their condition could limit their ability to tolerate the diabetes drugs they need. Finally, Fournier's Gangrene survivors will have to be hooked up to a catheter and a colostomy bag for the rest of their life. If you or a loved one has contracted Fournier's Gangrene you may qualify to file a claim against the drug's manufacturer for failing to warn of the potential to develop the genital flesh-eating disease.
Fournier's Gangrene is a form of necrotizing fasciitis that affects the genital area of diabetic patients taking certain drugs called SGLT2 blockers. If you are taking any of the following diabetes medications, please consult your physician immediately. Canagliflozin (Invokana, Invokamet, Invokamet XR), Dapagliflozin (Farxiga, Xigduo XR, Qtern), Empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR), and Ertugliflozin (Steglatro, Segluromet, Steglujan). The company websites for the drugs linked by the FDA as causing Fournier Gangrene have not addressed Fournier's specifically, but carry a standard warning for causing necrotising fasciitis: "Reports of necrotizing fasciitis of the perineum (Fournier's gangrene), a rare but serious and life-threatening necrotizing infection requiring urgent surgical intervention, have been identified in postmarketing surveillance in patients with diabetes mellitus receiving SGLT2 inhibitors. Cases have been reported in both females and males. Serious outcomes have included hospitalization, multiple surgeries, and death." Drugs that are used to fight cancer can cause sudden death and heart disease, and anti-diabetes medication is known to cause Fournier's gangrene where the only form of treatment is amputation.
The reason for the heightened concern among diabetic patients worried about contracting this heinous flesh-eating disease is due to the 12 cases of Fournier's Gangrene identified by the Food and Drug Administration (FDA) from 2013 to 2018 in both men and women over 38 years old. These patients all developed Fournier's Gangrene within two years from the start of taking SGLT2 inhibitor drugs.
If you are currently on one of the Fournier's Gangrene drugs above, do not discontinue taking your diabetes medication. In all likelihood, even if you are taking one of the anti-diabetic medications listed above, you will not contract Fournier's Gangrene and should continue to take your diabetes medication unless your doctors instruct you otherwise. You should, however, be aware of the earliest warning signs that you may have the disease. According to medicinenet.com, "The early stage of necrotizing fasciitis is characterized by symptoms of redness, swelling, and pain in the affected area. Blisters may be seen in the involved area of skin. Fever, nausea, vomiting, and other flu-like symptoms are common." (1) Other signs that of necrotizing fasciitis is in its more advanced stages include ulcers, blisters, black spots or changes in the color of the skin, fatigue, diarrhea, and nausea.
More Recent Diabetes Drug Infection Lawsuit News:
- Heart Disease Patients May Soon Be Prescribed Farxiga | 7/23/2020
- Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
- Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
- A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
- The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
- AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
- New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
- Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
- Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
- Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
- Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
- Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
- Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
- New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
- Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
- Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
- Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
- Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
- Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
- Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
- The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
- Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
- Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
- Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
- Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
- The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
- Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
- SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
- Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene | 10/24/2019
- Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
- Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
- Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
- Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
- Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
- SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
- Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
- Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
- Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
- There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
- Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
- Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
- Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
- The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
- Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
- Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
- Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
- People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
- Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
- World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene | 4/15/2019
- Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
- Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
- Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
- Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
- Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
- Scientists Are Encouraged By Data From Flesh-Eating Disease Studies | 2/25/2019
- The Brief History of Fournier's Gangrene | 2/20/2019
- FDA and CDC Warn About Flesh-Eating Diseases | 2/18/2019
- Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
- Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
- Fournier's Gangrene Frequently Asked Questions | 1/23/2019
- Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
- A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
- Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
- An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
- Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
- A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
- Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
- The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
- Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
- Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
- Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018
Lawyers for Fournier's Gangrene
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.